109 related articles for article (PubMed ID: 26925685)
21. PDGFRα promoter polymorphisms and expression patterns influence risk of development of imatinib-induced thrombocytopenia in chronic myeloid leukemia: A study from India.
Guru SA; Mir R; Bhat M; Najar I; Zuberi M; Sumi M; Masroor M; Gupta N; Saxena A
Tumour Biol; 2017 Oct; 39(10):1010428317713857. PubMed ID: 29019285
[TBL] [Abstract][Full Text] [Related]
22. OGG1 rs1052133 Polymorphism and Genetic Susceptibility to Chronic Myelogenous Leukaemia.
Hassan FM
Asian Pac J Cancer Prev; 2019 Mar; 20(3):925-928. PubMed ID: 30912416
[TBL] [Abstract][Full Text] [Related]
23. TP53 codon 72 polymorphism predicts chronic myeloid leukemia susceptibility and treatment outcome.
Weich N; Ferri C; Moiraghi B; Bengió R; Giere I; Pavlovsky C; Larripa I; Fundia A
Blood Cells Mol Dis; 2016 Jul; 59():129-33. PubMed ID: 27282582
[TBL] [Abstract][Full Text] [Related]
24. Common ataxia telangiectasia mutated haplotypes and risk of breast cancer: a nested case-control study.
Tamimi RM; Hankinson SE; Spiegelman D; Kraft P; Colditz GA; Hunter DJ
Breast Cancer Res; 2004; 6(4):R416-22. PubMed ID: 15217510
[TBL] [Abstract][Full Text] [Related]
25. Methylenetetrahydrofolate reductase C677T genetic polymorphisms and risk of leukaemia among the North Indian population.
Hussain SR; Naqvi H; Raza ST; Ahmed F; Babu SG; Kumar A; Zaidi ZH; Mahdi F
Cancer Epidemiol; 2012 Aug; 36(4):e227-31. PubMed ID: 22441130
[TBL] [Abstract][Full Text] [Related]
26. Genetic polymorphisms associated with increased risk of developing chronic myelogenous leukemia.
Bruzzoni-Giovanelli H; González JR; Sigaux F; Villoutreix BO; Cayuela JM; Guilhot J; Preudhomme C; Guilhot F; Poyet JL; Rousselot P
Oncotarget; 2015 Nov; 6(34):36269-77. PubMed ID: 26474455
[TBL] [Abstract][Full Text] [Related]
27. Association between DNA repair gene ATM polymorphisms and oral cancer susceptibility.
Bau DT; Chang CH; Tsai MH; Chiu CF; Tsou YA; Wang RF; Tsai CW; Tsai RY
Laryngoscope; 2010 Dec; 120(12):2417-22. PubMed ID: 21108427
[TBL] [Abstract][Full Text] [Related]
28. Association between ATM gene polymorphisms, lung cancer susceptibility and radiation-induced pneumonitis: a meta-analysis.
Yan Z; Tong X; Ma Y; Liu S; Yang L; Yang X; Yang X; Bai M; Fan H
BMC Pulm Med; 2017 Dec; 17(1):205. PubMed ID: 29246212
[TBL] [Abstract][Full Text] [Related]
29. Effects of ataxia telangiectasia mutated (ATM) genotypes and smoking habits on lung cancer risk in Taiwan.
Hsia TC; Tsai CW; Liang SJ; Chang WS; Lin LY; Chen WC; Tu CY; Tsai CH; Bau DT
Anticancer Res; 2013 Sep; 33(9):4067-71. PubMed ID: 24023351
[TBL] [Abstract][Full Text] [Related]
30. Single nucleotide polymorphism in PTEN-Long gene: A risk factor in chronic myeloid leukemia.
Ferri C; Weich N; Gutiérrez L; De Brasi C; Bengió MR; Zapata P; Fundia A; Larripa I
Gene; 2019 Apr; 694():71-75. PubMed ID: 30738963
[TBL] [Abstract][Full Text] [Related]
31. Association of MDR1 gene polymorphism (G2677T) with imatinib response in Egyptian chronic myeloid leukemia patients.
Elghannam DM; Ibrahim L; Ebrahim MA; Azmy E; Hakem H
Hematology; 2014 Apr; 19(3):123-8. PubMed ID: 23683876
[TBL] [Abstract][Full Text] [Related]
32. Clinical significance of BCR-ABL fusion gene subtypes in chronic myelogenous and acute lymphoblastic leukemias.
Ye YX; Zhou J; Zhou YH; Zhou Y; Song XB; Wang J; Lin L; Ying BW; Lu XJ
Asian Pac J Cancer Prev; 2014; 15(22):9961-6. PubMed ID: 25520136
[TBL] [Abstract][Full Text] [Related]
33. Expression of Hippo signaling pathway and Aurora kinase genes in chronic myeloid leukemia.
Marsola APZC; Simões BP; Palma LC; Berzoti-Coelho MG; Burin SM; de Castro FA
Med Oncol; 2018 Jan; 35(3):26. PubMed ID: 29387948
[TBL] [Abstract][Full Text] [Related]
34. The methylenetetrahydrofolate reductase (MTHFR) 677 C>T polymorphism increases the risk of developing chronic myeloid leukemia-a case-control study.
Bănescu C; Iancu M; Trifa AP; Macarie I; Dima D; Dobreanu M
Tumour Biol; 2015 Apr; 36(4):3101-7. PubMed ID: 25510667
[TBL] [Abstract][Full Text] [Related]
35. Antaxia-telangiectasia mutated gene polymorphisms and susceptibility to chromosomal damage among polycyclic aromatic hydrocarbons exposed workers.
Wang Y; Duan H; Dai Y; Bin P; Cheng J; Pan Z; Huang C; Leng S; Zheng Y
Sci Total Environ; 2009 Apr; 407(8):2615-20. PubMed ID: 19193393
[TBL] [Abstract][Full Text] [Related]
36. Lack of Association between the MiR146a Polymorphism and Susceptibility to Thai Childhood Acute Lymphoblastic Leukemia.
Chansing K; Pakakasama S; Hongeng S; Thongmee A; Pongstaporn W
Asian Pac J Cancer Prev; 2016; 17(5):2435-8. PubMed ID: 27268610
[TBL] [Abstract][Full Text] [Related]
37. ATM gene single nucleotide polymorphisms predict regimen-related gastrointestinal toxicity in patients allografted after reduced conditioning.
Kuba A; Raida L; Mrazek F; Schneiderova P; Kriegova E; Furst T; Furstova J; Faber E; Ambruzova Z; Papajik T
Biol Blood Marrow Transplant; 2015 Jun; 21(6):1136-40. PubMed ID: 25759145
[TBL] [Abstract][Full Text] [Related]
38. Influence of XPC, XPD, XPF, and XPG gene polymorphisms on the risk and the outcome of acute myeloid leukemia in a Romanian population.
Bănescu C; Iancu M; Trifa AP; Dobreanu M; Moldovan VG; Duicu C; Tripon F; Crauciuc A; Skypnyk C; Bogliș A; Lazar E
Tumour Biol; 2016 Jul; 37(7):9357-66. PubMed ID: 26779634
[TBL] [Abstract][Full Text] [Related]
39. ABCB1 haplotype is associated with major molecular response in chronic myeloid leukemia patients treated with standard-dose of imatinib.
Vivona D; Bueno CT; Lima LT; Hirata RD; Hirata MH; Luchessi AD; Zanichelli MA; Chiattone CS; Guerra-Shinohara EM
Blood Cells Mol Dis; 2012 Feb; 48(2):132-6. PubMed ID: 22134106
[TBL] [Abstract][Full Text] [Related]
40. Investigation of ICAM-1 and β3 integrin gene variations in patients with brain tumors.
Yilmaz U; Zeybek U; Kahraman OT; Kafadar AM; Toptas B; Yamak N; Celik F; Yaylim I
Asian Pac J Cancer Prev; 2013; 14(10):5929-34. PubMed ID: 24289603
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
